News

Bellerophon Therapeutics Announces Last Patient Has Completed Blinded Treatment in Phase 3 REBUILD Study for INOpulse® in Fibrotic Interstitial Lung Disease

Pivotal top-line data readout expected in mid-2023WARREN, N.J., May 11, 2023 (GLOBE NEWSWIRE) -- Bellerophon Therapeutics, Inc. (Nasdaq: BLPH) (“Bellerophon”…

11 months ago

Venus Concept Announces 1-for-15 Reverse Stock Split

TORONTO, May 11, 2023 (GLOBE NEWSWIRE) --  Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical…

11 months ago

Vir Biotechnology Announces First Patient Dosed in New Phase 2 Chronic Hepatitis B Virus Trial Evaluating Combinations of VIR-2218, VIR-3434, PEG-IFNα and an NRTI

– STRIVE is the first Phase 2 sub-protocol trial initiated under Vir’s new PREVAIL platform trial investigating the Company’s novel…

11 months ago

Orion Corporation: Managers’ transactions – Mikael Silvennoinen

ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MAY 2023 at 15.30 EEST          Orion Corporation: Managers’ transactions – Mikael Silvennoinen Orion Corporation…

11 months ago

Orion Corporation: Managers’ transactions – Agendum Oy

ORION CORPORATION MANAGERS’ TRANSACTIONS 11 MAY 2023 at 15.30 EEST          Orion Corporation: Managers’ transactions – Agendum Oy Orion Corporation…

11 months ago

Premier Health’s Subsidiary Canadian Health Care Agency Signs 2-year Agreement in British Columbia

MONTRÉAL, May 11, 2023 (GLOBE NEWSWIRE) -- Premier Health of America Inc. (TSXV: PHA) (the “Corporation” or “Premier Health”), a…

11 months ago

Grifols Launches AlphaID™ At Home, Enabling U.S. Consumers to Self-Screen for Genetic COPD

Now available in the U.S., this free, innovative genetic health risk service lets consumers screen for their risk of alpha1-antitrypsin…

11 months ago

Femasys Inc. to Showcase Four Products at the American College of Obstetricians and Gynecologists Annual Clinic & Scientific Meeting

ATLANTA, May 11, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women's needs by…

11 months ago

Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights

– Significant progress in Comera’s ongoing research collaboration with Regeneron, a leading U.S. biotechnology company – – Further development of…

11 months ago

Axis Research & Technologies Announces Integration of OMNIMED™ SmartOR™

Technology Platform Gives Medical Device Companies, Surgeons and Educators Data-Driven Insights to Improve Testing and Training Axis Research & Technologies,…

11 months ago